Sapanisertib (MLN0128)

Sapanisertib is a TORC1/2 inhibitor and an orally bioavailable raptor-mTOR and rictor-mTOR inhibitor with potential anti-tumor activity. The TORC1/2 inhibitor INK128 binds to and inhibits the TORC1 and TORC2 complexes of mTOR, which may lead to reduced tumor cell apoptosis and tumor cell proliferation.
Supplier Alfa Cytology
Product # BC0193
Pricing 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, inquire
Feedback